LU81890A1 - Nouvelles spiro-polycyclo-imidazolidinediones et compostion pharmaceutique les contenant - Google Patents

Nouvelles spiro-polycyclo-imidazolidinediones et compostion pharmaceutique les contenant Download PDF

Info

Publication number
LU81890A1
LU81890A1 LU81890A LU81890A LU81890A1 LU 81890 A1 LU81890 A1 LU 81890A1 LU 81890 A LU81890 A LU 81890A LU 81890 A LU81890 A LU 81890A LU 81890 A1 LU81890 A1 LU 81890A1
Authority
LU
Luxembourg
Prior art keywords
spiro
polycyclo
naphtho
group
nucleus
Prior art date
Application number
LU81890A
Other languages
English (en)
French (fr)
Inventor
R Sarges
J Belletire
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU81890A1 publication Critical patent/LU81890A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
LU81890A 1978-11-16 1979-11-15 Nouvelles spiro-polycyclo-imidazolidinediones et compostion pharmaceutique les contenant LU81890A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/961,335 US4181728A (en) 1978-11-16 1978-11-16 Spiro-polycyclicimidazolidinedione derivatives
US96133578 1978-11-16

Publications (1)

Publication Number Publication Date
LU81890A1 true LU81890A1 (fr) 1980-06-05

Family

ID=25504341

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81890A LU81890A1 (fr) 1978-11-16 1979-11-15 Nouvelles spiro-polycyclo-imidazolidinediones et compostion pharmaceutique les contenant

Country Status (23)

Country Link
US (1) US4181728A (nl)
JP (2) JPS6052157B2 (nl)
AR (1) AR222052A1 (nl)
AT (1) AT369742B (nl)
AU (1) AU515301B2 (nl)
BE (1) BE880065A (nl)
CA (1) CA1125294A (nl)
CH (1) CH642358A5 (nl)
DE (1) DE2946037A1 (nl)
DK (1) DK484479A (nl)
ES (1) ES486007A1 (nl)
FI (1) FI66385C (nl)
FR (1) FR2441627A1 (nl)
GB (1) GB2038315B (nl)
IE (1) IE49116B1 (nl)
IL (1) IL58730A (nl)
IT (1) IT1127231B (nl)
LU (1) LU81890A1 (nl)
NL (1) NL177689C (nl)
PH (1) PH15672A (nl)
PT (1) PT70452A (nl)
SE (1) SE447731B (nl)
YU (1) YU41678B (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490381A (en) * 1979-11-13 1984-12-25 Imperial Chemical Industries Plc 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
EP0065393B1 (en) * 1981-05-12 1984-12-27 Imperial Chemical Industries Plc Pyrrole derivatives
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
JPS59500618A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド スピロ―フルオロフルオレン化合物、その製造法およびアルド―スレダクターゼ活性を阻害する組成物
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
IL68314A0 (en) * 1982-04-15 1983-07-31 Alcon Lab Inc Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
DE3342933A1 (de) * 1983-11-26 1985-06-05 Horst G. 5190 Stolberg Schumann Regalfoerderzeug
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4576143A (en) * 1984-10-05 1986-03-18 Clark Iii William T Method of immune modification by means of extracorporeal irradiation of the blood
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
JPS6372140U (nl) * 1986-10-29 1988-05-14
JPS63119451U (nl) * 1987-01-30 1988-08-02
EP0536119A4 (en) * 1989-02-10 1993-08-04 Washington Research Foundation Immunoregulatory agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1032257B (de) * 1954-05-27 1958-06-19 Cutter Lab Verfahren zur Herstellung neuer Hydantoine
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4078064A (en) * 1976-08-18 1978-03-07 E. R. Squibb & Sons, Inc. 8H-Pyrazolo[4',3':5,6]pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidines
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives

Also Published As

Publication number Publication date
CA1125294A (en) 1982-06-08
SE447731B (sv) 1986-12-08
DK484479A (da) 1980-05-17
US4181728A (en) 1980-01-01
ATA729779A (de) 1982-06-15
SE7909439L (sv) 1980-05-17
YU41678B (en) 1987-12-31
YU277379A (en) 1983-01-21
FR2441627B1 (nl) 1983-06-03
CH642358A5 (fr) 1984-04-13
FI66385B (fi) 1984-06-29
AR222052A1 (es) 1981-04-15
IL58730A0 (en) 1980-02-29
ES486007A1 (es) 1980-09-01
IE49116B1 (en) 1985-08-07
PH15672A (en) 1983-03-11
FI793586A (fi) 1980-05-17
JPS60120870A (ja) 1985-06-28
JPS6144868B2 (nl) 1986-10-04
IT7927311A0 (it) 1979-11-15
PT70452A (en) 1979-12-01
JPS6052157B2 (ja) 1985-11-18
IE792184L (en) 1980-05-16
IL58730A (en) 1984-01-31
JPS5589268A (en) 1980-07-05
GB2038315A (en) 1980-07-23
NL177689C (nl) 1985-11-01
FR2441627A1 (fr) 1980-06-13
FI66385C (fi) 1984-10-10
AU515301B2 (en) 1981-03-26
AU5288079A (en) 1980-05-22
NL7908352A (nl) 1980-05-20
IT1127231B (it) 1986-05-21
BE880065A (fr) 1980-05-16
AT369742B (de) 1983-01-25
DE2946037A1 (de) 1980-05-22
GB2038315B (en) 1982-08-11
NL177689B (nl) 1985-06-03

Similar Documents

Publication Publication Date Title
LU81890A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et compostion pharmaceutique les contenant
FR2487353A1 (fr) Derives d'hydantoine, leur procede de preparation et leur application therapeutique
CH643546A5 (fr) Procede pour la preparation de derives d'hydantoine.
CH641759A5 (fr) Phenethanolamines et composition pharmaceutique antineoplastique les contenant.
EP0479631B1 (fr) Dérivés du spiro [4.5]décane leur procédé de préparation et les compositions pharmaceutiques les renfermant
CA1131230A (fr) Procede de preparation de nouveaux derives de 1,3-dihydro3-/1-/2-(2,3-dihydro 1,4-benzodioxin-2-yl) 2-hydroxy-ethyl/piperidin-4-yl/2h-indol-2-one
EP0008259A1 (fr) Nouveaux dérivés de la pipéridylbenzimidazolinone, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0150139A2 (fr) Dérivés de l'indole éthénylphénol, leurs sels, procédé de préparation, application à titre de médicaments,et compositions les renfermant
CH622512A5 (nl)
EP0117171B1 (fr) Dérivés aminés de la pyridazine substitués en position 6 par un hétérocycle ou un alicycle, procédé d'obtention et médicaments les contenant
CH633010A5 (fr) Derives de l'isoquinoleine, leur preparation et medicament qui les contient.
EP0395528A2 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
EP0233105B1 (fr) Compositions thérapeutiques à base de dérivés de 3-alkoxyflavones et nouveaux dérivés de 3-alkoxyflavones
LU84429A1 (fr) A titre de medicaments,certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
EP0201400A1 (fr) Dérivés du 4-phénylpropyl indole et leurs sels, leur procédé de préparation, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
FR2610627A1 (fr) Sels cristallins de l'acide (3s(z))-2(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfo-oxy)-3-azetidinyl)amino)-2-oxoethylidene)-amino)oxy)acetique, a action therapeutique
EP0395526B1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2701261A1 (fr) Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR2624856A1 (en) Tromethamine salt of 1-methyl-ss-oxo- alpha -(phenylcarbamoyl)-2-pyrrolepropionitrile
CA1123830A (fr) Procede de preparation de nouveaux esters du methyl-1 piperidinol-4
JPS63280080A (ja) 置換キノキサリル‐イミダゾリジン‐２，４‐ジオン
EP0226511B1 (fr) Dérivés de 5-phényl-1,4,5,6-tétrahydropyrimidine, procédé de préparation et utilisation en thérapeutique
CH641775A5 (fr) N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment.
EP0187096A1 (fr) Arylalcoyloxymethyl-2 morpholines, leur préparation et leur application en tant que médicaments utiles dans le traitement des troubles du système nerveux central
CH645115A5 (fr) Procede pour preparer la chloro-7 methyl-2 dihydro-3,3a 2h,9h-isoxazolo(3,2-b)(benzoxazine-1,3)one-9.